Template:Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency: Difference between revisions
No edit summary |
No edit summary |
||
Line 153: | Line 153: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency | [[Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency prevention|Prevention]] | ||
|- | |- | ||
! | ! |
Revision as of 19:04, 27 January 2016
Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency Microchapters |
Differentiating Multiple endocrine neoplasia type 1 from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency On the Web |
American Roentgen Ray Society Images of Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |
FDA on Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |
CDC on Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |
Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency in the news |
Blogs on Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |